Clinicogenomic Features and Outcomes of Adenoid Cystic Carcinoma With Central Nervous System Metastases: A Single-Institution Cohort Study - Summary - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Clinical and Genomic Characteristics of Adenoid Cystic Carcinoma with Central Nervous System Metastasis: Insights from a Single-Institution Study

  • By

  • Omar Elghawy

  • Jack Stylli

  • Martin Kurian

  • Eitan Halper-Stromberg

  • Aditi Singh

  • Christopher D'Avella

  • Lee Hartner

  • Roger B. Cohen

  • June 8, 2026

Share

Objective:

To describe the clinical characteristics, CNS disease patterns, molecular features, treatment modalities, and outcomes of patients with ACC and CNS involvement.

Approach:
  • Study Design: Retrospective cohort study of patients with biopsy-confirmed ACC and CNS involvement treated at the University of Pennsylvania.
  • Patient Identification: Patients were identified through an institutional cancer registry query and electronic medical record review.
  • CNS Involvement Classification: CNS involvement was categorized by dominant radiographic pattern, including hematogenous parenchymal metastasis, leptomeningeal disease, and neurotropic or perineural extension.
  • Treatment Assessment: CNS-directed treatment modalities and systemic therapies were abstracted, and radiographic responses were categorized.
  • Statistical Analysis: Descriptive statistics summarized baseline characteristics, and survival estimates were calculated using Kaplan–Meier methods.
Key Findings:
  • Seventeen patients with ACC and CNS involvement were identified.
  • Median age at initial ACC diagnosis was 54 years.
  • Most patients had primary tumors in the head and neck region.
Interpretation:

Limitations:
  • Small sample size limits the generalizability of findings.
  • Exploratory nature of statistical analyses due to cohort size.
Conclusion:

Original Source(s)

Related Content